‘Parasite’ actress Park So-dam diagnosed with papillary thyroid cancer

‘Parasite’ actress Park So-dam diagnosed with papillary thyroid cancer
‘Parasite’ actress Park So-dam

Park’s agency “ArtistCompany” revealed that the “Parasite” star is battling papillary thyroid cancer in a statement to CNN.

December 13, 2021
SHARE
South Korean actor Park So-dam was recently diagnosed with thyroid cancer.
The statement: Following a health check-up and surgery, Park’s agency “ArtistCompany” revealed that the “Parasite” star is battling papillary thyroid cancer in a statement to CNN.
  • Park was reportedly “very disappointed” to have her illness stop her from attending a promotional tour of her latest film “Special Delivery,” which is set to premier in South Korea on January 12, 2022. 
  • “The company would like to once again thank all the people for showing support for ‘Special Delivery’ and actress Park So Dam, as well as the actors and crew of ‘Special Delivery’ overcoming this difficult time together,” ArtistCompany stated.
  • “Actor Park So Dam will focus on her recovery so that she can see you all healthy in the future, and ArtistCompany will also do our best to help the actor recover her health,” the agency added.
  • According to the Columbia Thyroid Center, papillary thyroid cancer is “the most common type of thyroid cancer and one of the fastest growing cancer types with over 20,000 new cases a year.” While anyone can be diagnosed with papillary thyroid cancer at any age, it is most commonly seen in women before the age of 40. 
Park’s global breakout performance was in Bong Joon Ho’s 2019 film “Parasite,” which won Best Picture and Best Director at the 2020 Oscars. Park portrayed the role of a young woman, from an impoverished family, who poses as an art therapist in order to be hired by a wealthy family.
Featured Images via IGN
MOST READ
    HAPPENING NOW
      Michelle De Pacina

      Michelle De Pacina
      is a New York-based Reporter for NextShark

      SHARE THIS ARTICLE:

      RELATED STORIES FROM NEXTSHARK

      MORE STORIES FROM NEXTSHARK

      © 2023 NextShark, Inc. All rights reserved.